Publication:
Corrigendum: molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation

dc.contributor.coauthorKim, Jon Jin
dc.contributor.coauthorFichtner, Alexander
dc.contributor.coauthorCopley, Hannah C.
dc.contributor.coauthorGragert, Loren
dc.contributor.coauthorDello Strologo, Luca
dc.contributor.coauthorOh, Jun
dc.contributor.coauthorPape, Lars
dc.contributor.coauthorWeber, Lutz T.
dc.contributor.coauthorWeitz, Marcus
dc.contributor.coauthorKoenig, Jens
dc.contributor.coauthorKrupka, Kai
dc.contributor.coauthorToenshoff, Burkhard
dc.contributor.coauthorKosmoliaptsis, Vasilis
dc.contributor.departmentTIREX (Koç University Transplant Immunology Research Centre of Excellence)
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSüsal, Caner
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteResearch Center
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-12-29T09:37:35Z
dc.date.issued2023
dc.description.abstractIntroductionRejection remains the main cause of allograft failure in paediatric kidney transplantation and is driven by donor-recipient HLA mismatching. Modern computational algorithms enable assessment of HLA mismatch immunogenicity at the molecular level (molecular-mismatch, molMM). Whilst molMM has been shown to correlate with alloimmune outcomes, evidence demonstrating improved prediction performance against traditional antigen mismatching (antMM) is lacking. MethodsWe analysed 177 patients from the CERTAIN registry (median follow-up 4.5 years). molMM scores included Amino-Acid-Mismatch-Score (AAMS), Electrostatic-Mismatch-Score (EMS3D) and netMHCIIpan (netMHC1k: peptide binding affinity <= 1000 nM;netMHC: binding affinity <= 500 nM plus rank <2%). We stratified patients into high/low-risk groups based on risk models of DSA development. ResultsDonor-specific HLA antibodies (DSA) predominantly targeted the highest scoring molMM donor antigen within each HLA locus. MolMM scores offered superior discrimination versus antMM in predicting de novo DSA for all HLA loci;the EMS3D algorithm had particularly consistent performance (area under the receiver operating characteristic curve (AUC) >0.7 for all HLA loci vs. 0.52-0.70 for antMM). ABMR (but not TCMR) was associated with HLA-DQ molMM scores (AAMS, EMS3D and netMHC). Patients with high-risk HLA-DQ molMM had increased risk of graft function deterioration (50% reduction in baseline eGFR (eGFR50), adjusted HR: 3.5, 95% CI 1.6-8.2 high vs. low EMS3D). Multivariable modelling of the eGFR50 outcome using EMS3D HLA-DQ stratification showed better discrimination (AUC EMS3D vs. antMM at 2 years: 0.81 vs. 0.77, at 4.5 years: 0.72 vs. 0.64) and stratified more patients into the low-risk group, compared to traditional antMM. ConclusionMolecular mismatching was superior to antigen mismatching in predicting humoral alloimmunity. Molecular HLA-DQ mismatching appears to be a significant prognostic factor for graft function deterioration in paediatric kidney transplantation.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessgold, Green Published
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipThe CERTAIN registry received funding from Astellas and Novartis. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. All authors declare no other competing interests. The authors gratefully acknowledge the funding of the CERTAIN Registry by a grant from the Dietmar Hopp Stiftung, the European Society for Paediatric Nephrology (ESPN) and The German Society for Paediatric Nephrology (GPN). JKi acknowledges funding from a MRC NIHR fellowship (MR/V037900/1). CS acknowledges funding from the European Commision's Horizon 2020 Research and Innovation Programme (grant no. 952512). VK acknowledges funding from an NIHR Fellowship (PDF-2016-09-065) and as a Paul I.Terasaki Scholar.VK acknowledges funding from the National Institute for Health Research Blood and Transplant Research Unit (NIHRBTRU, Grant number: NIHR203332) in Organ Donation and Transplantation at the University of Cambridge in collaboration with Newcastle University and in partnership with NHS Blood and Transplant (NHSBT). The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, the Department of Healthor National Health Service Blood and Transplant
dc.description.volume14
dc.identifier.doi10.3389/fimmu.2023.1188527
dc.identifier.issn1664-3224
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85152244414
dc.identifier.urihttps://doi.org/10.3389/fimmu.2023.1188527
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22399
dc.identifier.wos965053600001
dc.keywordsKidney transplantation
dc.keywordsHLA mismatch
dc.keywordsMolecular mismatch
dc.keywordsEplets
dc.keywordsPredictive modeling
dc.keywordsAntibody mediated rejection (ABMR)
dc.keywordsDonor specific HLA antibodies
dc.language.isoeng
dc.publisherFrontiers Media Sa
dc.relation.grantnoAstellas
dc.relation.grantnoNovartis
dc.relation.grantnoDietmar Hopp Stiftung
dc.relation.grantnoEuropean Society for Paediatric Nephrology (ESPN)
dc.relation.grantnoGerman Society for Paediatric Nephrology (GPN)
dc.relation.grantnoMRC NIHR fellowship [MR/V037900/1]
dc.relation.grantnoEuropean Commision's Horizon 2020 Research and Innovation Programme [952512]
dc.relation.grantnoNIHR Fellowship [PDF-2016-09-065]
dc.relation.grantnoNational Institute for Health Research Blood and Transplant Research Unit [NIHR203332]
dc.relation.ispartofFrontiers in Immunology
dc.subjectImmunology
dc.titleCorrigendum: molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorSüsal, Caner
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1KUH (KOÇ UNIVERSITY HOSPITAL)
local.publication.orgunit1Research Center
local.publication.orgunit2TIREX (Koç University Transplant Immunology Research Centre of Excellence)
local.publication.orgunit2KUH (Koç University Hospital)
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublication29cd9ca5-6407-4582-92b6-788bc6f33efd
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscovery29cd9ca5-6407-4582-92b6-788bc6f33efd
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files